AZN

NASDAQ · Healthcare

AstraZeneca PLC

Q: What is AZN's stock price today?

AZN last closed at $181.65, down 0.99% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $9,651.00 and a high of $15,730.00. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What do Wall Street analysts say about AZN?

Among 36 analysts covering AZN, the consensus rating is Strong Buy — 29 rate it a buy, 5 hold, and 2 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: Is AstraZeneca PLC profitable?

AstraZeneca PLC generated $42.86B in revenue during fiscal year 2026, with $7.46B reaching the bottom line as net income. The net profit margin of 17.4% is solid for its sector.

Q: What is AZN's P/E ratio?

AZN trades at a P/E ratio of 30.51 on trailing earnings of $6.55 per share. That's above the S&P 500 historical average, suggesting the market expects above-average earnings growth ahead. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Mega-Cap Stocks Blue Chip Stocks Best Dividend Stocks

$181.65

-1.81 (-0.99%)

As of May 5, 7:00 PM ET ·

Day Range $180.00 — $181.98

52W Range $9,651.00 — $15,730.00

Open$180.99

Previous Close$183.46

Day High$181.98

Day Low$180.00

52W High$15,730.00

52W Low$9,651.00

Volume—

Avg Volume1.27M

Market Cap230.48B

P/E Ratio30.51

EPS$6.55

SectorHealthcare

Analyst Ratings

Strong Buy

36 analysts

29 Buy 5 Hold 2 Sell

Key Financials

	FY 2026	FY 2025
Revenue	42.86B	39.02B
Net Income	7.46B	6.11B
Profit Margin	17.4%	16.5%
EBITDA	12.99B	11.24B
Free Cash Flow	—	—
Rev Growth	+9.8%	+9.8%
Debt/Equity	0.61	0.61

Dividend

Dividend Yield1.59%

Annual Dividend$3.21

Payout Ratio48.6%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Healthcare Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
NVS	Novartis AG	$145.82	+0.83%	19.7	216.04B
RHHBY	Roche Holding AG	$50.28	-1.41%	—	—
SNY	Sanofi	$46.08	-1.07%	7.8	97.65B
GSK	GSK plc	$50.42	-0.16%	14.8	84.80B
NVO	Novo Nordisk A/S	$44.87	+1.08%	11.2	1.14T

AZN Frequently Asked Questions

What is AZN's stock price today?

AZN last closed at $181.65, down 0.99% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $9,651.00 and a high of $15,730.00. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What do Wall Street analysts say about AZN?

Among 36 analysts covering AZN, the consensus rating is Strong Buy — 29 rate it a buy, 5 hold, and 2 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Is AstraZeneca PLC profitable?

AstraZeneca PLC generated $42.86B in revenue during fiscal year 2026, with $7.46B reaching the bottom line as net income. The net profit margin of 17.4% is solid for its sector.

What is AZN's P/E ratio?

AZN trades at a P/E ratio of 30.51 on trailing earnings of $6.55 per share. That's above the S&P 500 historical average, suggesting the market expects above-average earnings growth ahead. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.